Advertisement
Advertisement
ICCC
Immucell Corp
11.00
USDSponsored
-0.02
-0.18%
Aug 07, 15:51 UTC -4
Closed
Pre-Market
10.97
-0.03
-0.24%
ICCC Earnings Reports
Positive Surprise Ratio
ICCC beat 2 of 3 last estimates.
67%
Next Report
In 3 Days
Date of Next Report
Aug 13, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Immucell Corp earnings per share and revenue
On May 14, 2026, ICCC reported earnings of 0.21 USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 10.36 million, compared to an expected --, with a --% difference. The market reacted with a +7.99% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.16
Surprise
-1.20%
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
FAQ
What were Immucell Corp's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Immucell Corp reported EPS of $0.21, missing estimates by --, and revenue of $10.36M, -- -- expectations.
How did the market react to Immucell Corp's Q1 2026 earnings?
The stock price moved up 7.99%, changed from $8.26 before the earnings release to $8.92 the day after.
When is Immucell Corp expected to report next?
The next earning report is scheduled for Aug 13, 2026.
What are the forecasts for Immucell Corp's next earnings report?
Based on --
analysts, Immucell Corp is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement